Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Keratorefractive Lenticule Extraction (KLEx) Versus Femtosecond Laser-assisted in Situ Keratomileusis (FS-LASIK) for the Treatment of Myopia and Compound Myopic Astigmatism

NCT06477081 is registered in ClinicalTrials.gov with Instituto de Oftalmología Fundación Conde de Valenciana as lead sponsor.

NCT NCT06477081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06477081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Keratorefractive Lenticule Extraction (KLEx) Versus Femtosecond Laser-assisted in Situ Keratomileusis (FS-LASIK) for the Treatment of Myopia and Compound Myopic Astigmatism
Lead sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 1, 2024
Completion date
March 1, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

astigmatism, myopia, myopic astigmatism